Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
10 February 2021 - 11:00PM
Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical
technology company focused on designing, developing and marketing
products that improve the quality of life for patients who suffer
from psychiatric disorders, today announced that Keith Sullivan,
President and Chief Executive Officer, and Steve Furlong, Chief
Financial Officer, will be participating in a virtual fireside chat
as part of the BTIG Virtual MedTech, Digital Health, Life Science
& Diagnostic Tools Conference on Wednesday, February 17, 2021
at 4:30pm ET.
A live audio webcast of the fireside chat will be available
online at the investor relations page of the Company’s website at
ir.neuronetics.com. A replay of the webcast will be archived on the
website for approximately 90
days.About NeuroneticsNeuronetics, Inc. is a
commercial-stage medical technology company focused on designing,
developing, and marketing products that improve the quality of life
for patients who suffer from psychiatric disorders. Its commercial
product, the NeuroStar® Advanced Therapy System, is a non-invasive
and non-systemic office-based treatment that uses transcranial
magnetic stimulation, or TMS, to create a pulsed, MRI-strength
magnetic field that induces electrical currents designed to
stimulate specific areas of the brain associated with mood. The
system is cleared by the United States Food and Drug
Administration, or FDA, for the treatment of major depressive
disorder in adult patients who have failed to achieve satisfactory
improvement from prior antidepressant medication in the current
episode. NeuroStar is also available in other parts of the world,
including Japan, where it is listed under Japan’s national health
insurance. Additional information can be found at
www.neuronetics.com.Investor Contact:Mark R.
KlausnerWestwicke
Partners443-213-0501ir@neuronetics.comMedia
Contact:Chelsey MankoVault
Communications610-455-2778cmanko@vaultcommunications.com
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From Apr 2024 to May 2024
Neuronetics (NASDAQ:STIM)
Historical Stock Chart
From May 2023 to May 2024